Ionis Pharmaceuticals, Inc. Payments to Acquire Other Productive Assets
Ionis Pharmaceuticals, Inc. (IONS) reported Payments to Acquire Other Productive Assets of $3.18 million for the 6-month period ending 2021-06-30, per its 10-Q filed 2021-08-04.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireOtherProductiveAssets · last filed 2021-08-04
- Ionis Pharmaceuticals, Inc. payments to acquire other productive assets for the quarter ending 2021-06-30 was $1.95M, a 7.79% decline year-over-year.
- Ionis Pharmaceuticals, Inc. payments to acquire other productive assets for the quarter ending 2021-03-31 was $1.23M, a 35.84% increase year-over-year.
- Ionis Pharmaceuticals, Inc. payments to acquire other productive assets for the quarter ending 2020-06-30 was $2.12M.
- Ionis Pharmaceuticals, Inc. payments to acquire other productive assets for the quarter ending 2020-03-31 was $904.00K.
- Ionis Pharmaceuticals, Inc. payments to acquire other productive assets for fiscal 2020 was $5.93M, a 10.25% increase from fiscal 2019.
- Ionis Pharmaceuticals, Inc. payments to acquire other productive assets for fiscal 2019 was $5.38M, a 32.96% increase from fiscal 2018.
- Ionis Pharmaceuticals, Inc. payments to acquire other productive assets for fiscal 2018 was $4.04M.
| Period end | Payments to Acquire Other Productive Assets 3 month | Payments to Acquire Other Productive Assets 6 month | Payments to Acquire Other Productive Assets 12 month |
|---|---|---|---|
| 2021-06-30 | $1.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | $3.18M 10-Q · filed 2021-08-04 | |
| 2021-03-31 | $1.23M 10-Q · filed 2021-05-05 | ||
| 2020-12-31 | $5.93M 10-K · filed 2021-02-24 | ||
| 2020-06-30 | $2.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | $3.02M 10-Q · filed 2021-08-04 | |
| 2020-03-31 | $904.00K 10-Q · filed 2021-05-05 | ||
| 2019-12-31 | $5.38M 10-K · filed 2021-02-24 | ||
| 2018-12-31 | $4.04M 10-K · filed 2021-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |